A lesson from Placental Transfer and Fetal Effects of Anesthetic Drugs

Volatile Anesthetics and Nitrous Oxide: Placental Transfer and Fetal Effects

Volatile Anesthetics

Volatile anesthetics, including sevoflurane, isoflurane, and desflurane, are frequently used in obstetric anesthesia due to their ease of administration, predictable effects, and rapid onset. These agents are highly lipid-soluble, which allows them to penetrate biological membranes, including the placenta, with ease. Additionally, their low molecular weights (168 to 200 Da) further facilitate rapid placental transfer, and the fetal-to-maternal ratio rises with the duration of administration: for isoflurane the UV/MV ratio is about 0.7 after a typical induction-to-delivery interval. Pregnancy also lowers the minimum alveolar concentration (MAC) by about 30%, so less agent is needed for the same depth. In practice the agent is run at about 0.5 to 1 MAC (often with 50% nitrous oxide) between induction and delivery; with an induction-to-delivery interval under about 10 minutes at these concentrations, neonatal Apgar scores are not depressed. A long interval at higher concentrations is what loads the fetus. The volatile agents also relax the uterus in a dose-dependent way, which is why the concentration is reduced to about 0.5 MAC (supplemented with nitrous oxide, an opioid or propofol) after delivery to limit uterine atony and bleeding.

Timeline of a cesarean under general anesthesia: induction, a plateau of 0.5 to 1 MAC with 50 percent nitrous oxide before delivery, then a step down to about 0.5 MAC after delivery, with notes for each phase

Fetal Effect: The primary fetal effects of volatile anesthetics stem from their ability to induce neonatal sedation and respiratory depression. Neonates exposed to these agents immediately before birth may present with respiratory distress, often requiring supplemental oxygen or more advanced respiratory support until the effects of the anesthetics wear off. This respiratory compromise occurs because the anesthetic agents can impair the neonate's ability to initiate and maintain effective breathing, leading to hypoventilation. Although these effects are usually transient, they necessitate careful monitoring in the immediate postpartum period. Prolonged exposure to volatile anesthetics can exacerbate these effects, leading to more pronounced neonatal depression, which might delay spontaneous breathing. The remedy is ventilation, not time for metabolism: volatile agents are eliminated almost entirely through the lungs, so once the neonate is breathing effectively (or is given positive-pressure ventilation) the agent is exhaled within minutes and the depression lifts.

Nitrous Oxide

Nitrous oxide is another inhalation agent widely used in obstetric anesthesia, particularly for its analgesic properties and rapid onset of action. Nitrous oxide is a small molecule with a high diffusion rate, which allows it to rapidly cross the placenta and reach the fetal circulation. It is typically used for pain relief during labor as a self-administered 50% mixture with oxygen, and it is considered safe at that concentration: it crosses the placenta within minutes (UV/MV ratio about 0.8), but intermittent 50% nitrous oxide in labor has not been shown to affect Apgar scores, umbilical blood gases or neonatal neurobehavior. The theoretical concerns described below apply to prolonged, continuous administration at higher concentrations, as during a cesarean under general anesthesia with a long induction-to-delivery interval.

Fetal Effect: One of the main theoretical fetal concerns with nitrous oxide is neonatal diffusion hypoxia. Nitrous oxide is far more soluble in blood than nitrogen, so when a neonate loaded with it takes its first breaths, the gas leaves the blood and pours into the alveoli faster than nitrogen is taken up, diluting the alveolar oxygen and carbon dioxide for the first few minutes of breathing. If the neonate has received a large, continuous dose immediately before delivery, this dilution can lower alveolar oxygen just as breathing is being established. The remedy is effective ventilation: the Neonatal Resuscitation Program begins with 21% oxygen for term newborns and titrates oxygen to preductal saturation targets, so oxygen is not given routinely because of nitrous exposure, but a neonate who is not breathing well after a nitrous-based general anesthetic receives positive-pressure ventilation, which washes the gas out within minutes. The effects of nitrous oxide exposure are short-lived, and the neonate recovers without long-term consequences.

Schematic of a neonatal alveolus with nitrous oxide leaving the capillary blood into the alveolus and diluting oxygen during the first breaths, with the two responses: nothing if breathing well, positive-pressure ventilation if not

Free lesson

This lesson is part of “Placental Transfer and Fetal Effects of Anesthetic Drugs”

Lesson 4 of 15

Unlock all 15 lessons, the quiz, and 2 Class A credits. 2 of those count toward pharmacology.

More free lessons from this module